Document Detail


Cell sheet technology for heart failure.
MedLine Citation:
PMID:  23437937     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heart failure is a life threatening disorder in worldwide and many papers reported about myocardial regeneration through surgical method induced by LVAD, cellular cardiomyoplasty (cell injection), tissue cardiomyoplasty (bioengineered cardiac graft implantation), in situ engineering (scaffold implantation), and LV restrictive devices. Some of these innovated technologies have been introduced to clinical settings. This review article provides summary about recent basical and clinical advances about myocardial regeneration induced by bioengineered cardiac tissue.
Authors:
Yoshiki Sawa; Shigeru Miyagawa
Related Documents :
24723087 - Management of fulminant myocarditis: a diagnosis in search of its etiology but with the...
23398627 - Correlation between total atrial conduction time estimated via tissue doppler imaging (...
15170707 - Vascular complications following coronary intervention correlate with long-term cardiac...
23054217 - A new electrocardiogram algorithm for diagnosing loss of ventricular capture during car...
8496827 - Effect of mci-154, a cardiotonic agent, on regional contractile function and myocardial...
9362617 - Opportunities for potential cost saving in the management of acute myocardial infarction.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current pharmaceutical biotechnology     Volume:  14     ISSN:  1873-4316     ISO Abbreviation:  Curr Pharm Biotechnol     Publication Date:  2013  
Date Detail:
Created Date:  2013-02-26     Completed Date:  2013-08-09     Revised Date:  2014-09-29    
Medline Journal Info:
Nlm Unique ID:  100960530     Medline TA:  Curr Pharm Biotechnol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  61-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Heart Failure / therapy*
Humans
Myoblasts, Cardiac / transplantation*
Myocytes, Cardiac / transplantation
Regeneration
Tissue Engineering / methods*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-viral gene delivery methods.
Next Document:  Modular Pyridine Synthesis from Oximes and Enals through Synergistic Copper/Iminium Catalysis.